CrossLife Technologies Overview
- Year Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1000K
- Investors
-
4
CrossLife Technologies General Information
Description
Developer of molecular diagnostics technologies designed to detect infectious and non-communicable diseases. The company's molecular diagnostics technologies are based on nucleic acid and DNA and it develops technologies into pathogen detection tests for many infectious diseases including HIV, malaria, chikungunya, and flu, enabling doctors to detect infectious pathogens directly from diverse sample types without sample preparation, polymerase chain reaction or instrumentation.
Contact Information
Website
www.crosslifetech.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Other Healthcare Technology Systems
Decision/Risk Analysis
Primary Office
- 5937 Darwin Court
- Suite 105
- Carlsbad, CA 92008
- United States
+1 (760) 000-0000
CrossLife Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 15-Jan-2021 | $1000K | Completed | Startup | ||
| 8. Grant | 15-Sep-2019 | 00000 | Completed | Startup | ||
| 7. Grant | 12-Sep-2019 | 00000 | Completed | Startup | ||
| 6. Grant | 15-Mar-2019 | 000000 | Completed | Startup | ||
| 5. Grant | 01-Jan-2018 | 00000 | Completed | Startup | ||
| 4. Grant | 01-Jan-2017 | 00000 | Completed | Startup | ||
| 3. Grant | 01-Jul-2016 | 00000 | Completed | Startup | ||
| 2. Grant | 10-Mar-2016 | $2.43M | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
CrossLife Technologies Patents
CrossLife Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4058580-A1 | Engineered gyri-like mutein aptamers, and related methods | Pending | 13-Nov-2019 | 0000000000 | |
| US-20210139958-A1 | Engineered gyri-like mutein aptamers, and related methods | Pending | 13-Nov-2019 | 0000000000 | |
| US-20200354800-A1 | Rapid nucleic acid detection without sample preparation | Active | 08-May-2019 | 0000000000 | |
| US-11685960-B2 | Rapid nucleic acid detection without sample preparation | Active | 08-May-2019 | 000000000 | 0 |
| US-10626447-B2 | Methods and compositions of non-enzymatic amplification and direct detection of nucleic acids | Active | 13-Mar-2015 | C12Q1/6809 | 0 |
CrossLife Technologies Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Hyundae Cho Ph.D | Founder, President, Chief Executive Officer & Board Member |
CrossLife Technologies Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Bio, Tech and Beyond | Accelerator/Incubator | 000 0000 | 000000 0 |